Dyfyniad APA

Mamidi, S., Cinci, M., Hasmann, M., Fehring, V., & Kirschfink, M. (2013). Lipoplex mediated silencing of membrane regulators (CD46, CD55 and CD59) enhances complement‐dependent anti‐tumor activity of trastuzumab and pertuzumab. Mol Oncol.

Dyfyniad Arddull Chicago

Mamidi, Srinivas, Marc Cinci, Max Hasmann, Volker Fehring, and Michael Kirschfink. "Lipoplex Mediated Silencing of Membrane Regulators (CD46, CD55 and CD59) Enhances Complement‐dependent Anti‐tumor Activity of Trastuzumab and Pertuzumab." Mol Oncol 2013.

Dyfyniad MLA

Mamidi, Srinivas, et al. "Lipoplex Mediated Silencing of Membrane Regulators (CD46, CD55 and CD59) Enhances Complement‐dependent Anti‐tumor Activity of Trastuzumab and Pertuzumab." Mol Oncol 2013.

Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.